Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature 2017, 546, 498-503. [CrossRef]S. Kamerkar et al., "Exosomes facilitate therapeutic targeting of onco- genic KRAS in pancreatic cancer," Nature 546, 498-503 (2017)....
0 0 M O N T H 2 0 1 7 | V O L 0 0 0 | N A T U R E | 1ARTICLEdoi:10.1038/nature22341Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancerSushrut Kamerkar 1 , Valerie S. LeBleu 1 , Hikaru Sugimoto 1 , Sujuan Yang 1 , Carolina F. Ruivo 2 , Son...
et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature546, 498–503 (2017). CAS PubMed PubMed Central Google Scholar Qi, H. et al. Blood exosomes endowed with magnetic and targeting properties for cancer therapy. ACS Nano.10, 3323–3333 (2016). CAS...
Kamerkar S, LeBleu VS, Sugimoto H, Yang S, Ruivo CF, Melo SA, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546(7659):498–503. CASPubMedPubMed CentralGoogle Scholar Usman WM, Pham TC, Kwok YY, Vu LT, Ma V, Peng B, et al....
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546(7659):498–503. Article CAS PubMed PubMed Central Google Scholar Yeo LY, Chang HC, Chan PP, Friend JR. Microfluidic devices for bioapplications. Small. 2011;7(1):12–48. Article CAS PubMed ...
Because exosomes can freely travel between the center and periphery, brain-derived exosomes can reflect the state of the brain, which has considerable advantages in diagnosis and treatment. In addition, administration of engineered exosomes can improve therapeutic efficacy, allow lesion targeting, ensure...
Currently, There is no comprehensive review that explores the potential use of exosomes as a therapeutic and drug delivery vehicle for NDs. This review aims to investigate potential therapeutic effect of exosomes by targeting signaling pathways involved in autophagy, apoptosis, inflammation, and ...
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer Nature, 546 (7659) (Jun 22 2017), pp. 498-503 CrossrefView in ScopusGoogle Scholar [11] H. Peng, W. Ji, R. Zhao, J. Yang, Z. Lu, Y. Li, et al. Exosome: a significant nano-scale drug delivery carrier...
et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature546, 498–503 (2017). CAS PubMed PubMed Central Google Scholar Luan, X. et al. Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharm. Sin.38, 754–763 (2017). CAS...
For example, miR-567-enriched exosomes reversed trastuzumab resistance via suppressing autophagy by targeting ATG5(autophagy related 5), promising to serve as a potential therapeutic target for breast cancer patients [49]. As for the value of exosomes in tumor diagnosis and prognosis, there is a ...